Cargando…

P019: Unfavorable prognostic value of the predominance of THRLBCL-like histopathological growth patterns in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)

Detalles Bibliográficos
Autores principales:	Dorokhina, Elena, Moiseeva, T.N., Kovrigina, A.M., Shupletsova, Irirna, Al-Radi, L.S., Chabaeva, Yu. A., Mangasarova, Ya.K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Advanced Stages
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621509/ http://dx.doi.org/10.1097/01.HS9.0000890644.44392.28

Ejemplares similares

P007: Comparative efficacy of the R-BEACOPP-14 and R-CHOP regimens in the treatment of patients with advanced stages of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with THRLBCL-like histopathological growth patterns in the tumor biopsy
por: Dorokhina, Elena, et al.
Publicado: (2022)

P033: Clinical significance of the severity of THRLBCL-like areas in nodular lymphocyte predominant Hodgkin lymphoma
por: Shupletsova, Irirna, et al.
Publicado: (2022)

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells
por: Seliem, Rania M., et al.
Publicado: (2011)

P012: Nodular Lymphocyte-predominant Hodgkin Lymphoma a rare disease with good prognosis: a retrospective multicenter experience
por: Pierdomenico, Francesca, et al.
Publicado: (2022)

A Case of Chemotherapy-Refractory “THRLBCL like Transformation of NLPHL” Successfully Treated with Lenalidomide
por: Siricilla, Mamatha, et al.
Publicado: (2018)

P1092: NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL): HISTOLOGYCAL AND CLINICAL REVIEW IN A SINGLE CENTRE.
por: Rámila, E., et al.
Publicado: (2022)

T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies
por: Eichenauer, Dennis A., et al.
Publicado: (2022)

Nodular Lymphocyte Predominant Hodgkin Lymphoma of the Thyroid
por: Tavares Bello, Carlos, et al.
Publicado: (2016)

Nodular Lymphocyte Predominant Hodgkin Lymphoma of the Ileum
por: Rangan, Aruna, et al.
Publicado: (2017)

P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
por: Mocikova, Heidi, et al.
Publicado: (2022)

Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma
por: Visser, Lydia, et al.
Publicado: (2016)

P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin’s lymphoma.
por: Mangasarova, Ya.K., et al.
Publicado: (2022)

Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma
por: Thurner, Lorenz, et al.
Publicado: (2020)

Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
por: Tyran, Marguerite, et al.
Publicado: (2014)

Progress in understanding the biology of nodular lymphocyte-predominant Hodgkin lymphoma
por: Straus, David J.
Publicado: (2021)

The Importance of Excisional Biopsy in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma
por: Juarez, Angel, et al.
Publicado: (2023)

Expanding the bacterial origins of nodular lymphocyte-predominant Hodgkin lymphoma
por: Gandhi, Maher K., et al.
Publicado: (2023)

Nodular Lymphocyte-Predominant Hodgkin Lymphoma in Progressive Transformation of Germinal Centers
por: Bailey, C. Eric, et al.
Publicado: (2017)

Primary nodular lymphocyte-predominant Hodgkin lymphoma of uterine cervix mimicking leiomyoma
por: Li, Wan-Shan, et al.
Publicado: (2015)

Adult nodular lymphocyte‐predominant Hodgkin lymphoma: treatment modality utilization and survival
por: Alonso, Clayton, et al.
Publicado: (2018)

Nodular lymphocyte predominance Hodgkin lymphoma of the parotid gland: a case report
por: Alves, Carlos Augusto Ferreira, et al.
Publicado: (2012)

Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion
por: Sidda, Adarsh, et al.
Publicado: (2022)

Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Patient with Familial Mediterranean Fever
por: Belia, Marina, et al.
Publicado: (2022)

T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group
por: Borchmann, Peter, et al.
Publicado: (2022)

P017: The role of baseline bulk and dissemination measures as predictors of progression in advanced Hodgkin lymphoma
por: Taszner, Michal, et al.
Publicado: (2022)

P014: Prognostic significance of nutritional indexes (CONUT and PNI) in classical Hodgkin lymphoma patients
por: Sousa, Rita Costa E., et al.
Publicado: (2022)

T022: Sharing decisions regarding radiotherapy for Hodgkin lymphoma: a qualitative study of the experiences of patients and clinicians in the UK
por: Shakir, Rebecca, et al.
Publicado: (2022)

P018: Treatment outcomes in classical Hodgkin lymphoma (HL): 5-year update report from the Brazilian Prospective Registry
por: Biasoli, Irene, et al.
Publicado: (2022)

Autoimmune Hemolytic Anemia and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Rare Association
por: Salmeron, Géraldine, et al.
Publicado: (2013)

Composite t(14;18)-Negative Follicular Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma
por: O'Neill, John Patrick, et al.
Publicado: (2018)

Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma
por: Akhtar, Saad, et al.
Publicado: (2021)

A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type
por: Rosenfeldt, Mathias T., et al.
Publicado: (2020)

Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation
por: Paschold, Lisa, et al.
Publicado: (2021)

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
por: Posthuma, Hidde L. A., et al.
Publicado: (2021)

Pitfalls in the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma: Variant Patterns, Borderlines and Mimics
por: Younes, Sheren, et al.
Publicado: (2021)

Digital pathology in pediatric nodular lymphocyte-predominant Hodgkin lymphoma: correlation with treatment response
por: Sereda, Sergej, et al.
Publicado: (2023)

Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Rare Lymphoma with Isolated Hepatic Presentation
por: Freitas, Bruno David, et al.
Publicado: (2023)

P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose
por: Almeida, Cátia, et al.
Publicado: (2022)

P013: Outcomes of first-line treatment (FL) of classical Hodgkin lymphoma (cHL) in Argentina: a real life multicenter retrospective study
por: Laura, Korin, et al.
Publicado: (2022)

P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
por: Dragičević, Ida Hude, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6sq1dsuc8k2bnrjo8qd98dtflu